EcoDrugPlus

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSVVUG00000017500
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSVVUG00000021876
Gene Symbol: DPYD
3 Cross references
220 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSVVUG00000018592
Gene Symbol: DPP4
3 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSVVUG00000010010
Gene Symbol: DDR2
3 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSVVUG00000001913
Gene Symbol: DRD1
3 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSVVUG00000016119
Gene Symbol: DRD2
3 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSVVUG00000022170
Gene Symbol: DRD3
3 Cross references
206 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSVVUG00000015003
Gene Symbol: DRD5
1 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSVVUG00000015843
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSVVUG00000007066
Gene Symbol: EGLN1
2 Cross references
232 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSVVUG00000005631
Gene Symbol: EGLN2
3 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSVVUG00000029949
Gene Symbol: EGLN3
2 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).